Gujarat Terce Laboratories Limited (BSE: 524314)
Health Care · Pharmaceuticals · IN
Rs36.20
+2.96% today · -36.0% 1Y
Gujarat Terce Laboratories Limited (BSE: 524314) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.91M.
Over the last twelve months the share price has lost 36.0%, trading between 29.00 and 59.78.
Tweenvest scores Gujarat Terce Laboratories Limited across four factors: quality 79/100, value 49/100, growth 10/100. Its strongest factor is quality.
524314 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.91M
- Revenue (TTM)
- $4.83M
- P/E
- 13.42
- EPS
- 2.70
- Dividend yield
- —
- Beta (5Y)
- 0.95
- 52-week high
- Rs59.78
- 52-week low
- Rs29.00
- Avg volume (3M)
- —
- Shares outstanding
- 7.79M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Emmaus Life Sciences, Inc.OTCPK: EMMA | $3.00M | $0.04 | +1.42% |
| Nextleaf Solutions Ltd.CNSX: OILS | $2.98M | CA$0.03 | -16.67% |
| Medicamen Organics LimitedNSEI: MEDIORG | $2.94M | Rs23.35 | -4.89% |
| Nextgen Biomed LtdTASE: NXGN-M | $2.93M | ₪— | — |
| Invion LimitedASX: IVX | $2.90M | AU$0.04 | -2.56% |
| Noveris Health Sciences Inc.CNSX: NVRS | $2.87M | CA$0.07 | -12.50% |
| Eastgate Biotech Corp.OTCPK: ETBI | $2.86M | $0.00 | -46.00% |
| SOHM, Inc.OTCPK: SHMN | $2.81M | $0.00 | +7.78% |
Figures last refreshed Oct 11, 2026.